Eucalyptus COVID-19

Published: 24 November 2022| Version 2 | DOI: 10.17632/grcpkdty7f.2
Muthiah Nur Afifah


data before being processed and has been grouped based on patients who received treatment and the control group


Steps to reproduce

Patients were assigned into two groups. The number of participants who received treatment, lost and excluded, and analysed for outcome measurement are shown in Fig 1. The first group was only given standard COVID-19 treatment; oseltamivir 75 mg 12 hourly a day, azithromycin 500 mg a day, vitamin C 300 mg 12 hourly a day, zinc 20 mg a day, and a tablet of complex vitamin B. In comparison, the treated group was given Standard COVID-19 and adjuvant therapy. Eucalyptus oil as adjuvant therapy was given through inhalation by applying it on the surgery mask four times a day, 45 minutes duration in each session for 15 days.


Adjuvant Therapy, Symptom Management of Clinical Population, COVID-19